Buy Package

  • -4%
    Placeholder

    TRIPLE MARKER TEST (PE DELFIA)

    0 out of 5
    2,600.00 2,500.00
  • -20%
    Placeholder

    TROPONIN – T, HIGH SENSITIVE

    0 out of 5
    2,000.00 1,600.00
  • Placeholder

    TRYPSIN

    0 out of 5

    Trypsin (or trypsinogen) is considered a specific indicator of pancreatic damage. Increased values over the determined normal range may indicate inflammatory pancreatic condition.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • -20%
    Placeholder

    TSH (THYROID STIMULATING HORMONE)

    0 out of 5

    TSH is an early indicator of decreased thyroid reserve. This assay helps to diagnose hypothyroidism and hyperthyroidism, monitors T4 replacement or T4 suppressive therapy and quantifies TSH levels in the subnormal range.

    • Pre-test Information:

      Sample to be given at the same time in followup cases

    • Report Delivery:

      Daily

    250.00 200.00
  • -8%
    Placeholder

    TSH (THYROID STIMULATING HORMONE), ULTRASENSITIVE

    0 out of 5

    This assay is used in the differential diagnosis of Hypothyroidism, as an aid in the diagnosis of Primary Hyperthyroidism, prediction of TRH stimulated TSH response and monitoring patients on thyroid replacement therapy.

    • Test Type:

      Blood

    • Pre-test Information:

      Sample to be given at the same time in followup cases

    • Report Delivery:

      Daily

    400.00 370.00
  • Placeholder

    TSH ANTIBODY

    0 out of 5

    Patients with autoimmune thyroid disease can develop antibodies to TSH which interfere with TSH measurement. This test aids in understanding disparate laboratory and clinical findings.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • -6%
    Placeholder

    TSH RECEPTOR ANTIBODY

    0 out of 5

    This assay is used as an aid in the differential diagnosis and monitoring of Grave’s disease. Measurement of TSH receptor antibody in the last trimester of pregnancy in a patient with history of thyroid disease helps in assessing the risk of thyroid disease in neonates.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample Daily by 4 pm; Report Same day

     

    4,000.00 3,750.00
  • Placeholder

    TSH STIMULATION BY TRH (THYROTROPIN RELEASING HORMONE)

    0 out of 5

    This test is used for suspected Hypothalamic – Pitutary dysfunction.

    • Pre-test Information:

      Overnight fasting mandatory. Injection TRH is not supplied by LPL

    • Report Delivery:

      Daily

  • Placeholder

    TSH, NEWBORN SCREEN

    0 out of 5

    This test should be used only in neonates to screen for thyroid disorders.

    • Pre-test Information:

      Clinical details and drug history must accompany sample.

    • Report Delivery:

      Sample by Tue / Thu / Sat 5 pm; Report 2 days

  • Placeholder

    TSI; THYROID STIMULATING IMMUNOGLOBULIN

    0 out of 5

    Graves disease is a classic form of hyperthyroid disease, affecting approximately 0.4% of the population in the United States. It is caused by IgG immunoglobulins, collectively known as thyroid stimulating immunoglobulins (TSI). Patients who are candidates for anti-thyroid drug therapy may not respond to this treatment when TSI levels are markedly elevated. The determination of TSI can also assist in predicting hyperthyroidism in neonates due to placental transmission of the immunoglobulins from mothers with hyperthyroidism.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • Placeholder

    U1RNP ANTIBODIES

    0 out of 5

    U1RNP antibody in combination with Smith antibody provides additional support for the diagnosis of SLE. A positive U1RNP antibody alone with the corresponding clinical history supports the diagnosis of Mixed connective tissue disease.

    • Pre-test Information:

      Overnight fasting is preferred

    • Report Delivery:

      Sample by Tue / Fri 9 am; Report Same day

  • Placeholder

    UGT1A1 GENE POLYMORPHISM (NUCLEOTIDE ‘TA’ REPEATS) DETECTION

    0 out of 5

    UGT1A1 gene polymorphism is associated with Gidlbert syndrome, Crigler Nijjar syndrome and with irinotecan toxicity

    • Pre-test Information:

      No Special preparation required

    • Report Delivery:

      Sample Wed / Sat by 11 am; Report 10 days